References
- Scott DG, Bacon PA, Tribe CR. Systemic vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 1981;60: 288–97.
- Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. Factors associated with the develop-ment of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis. 1996;55:190–2.
- Sokoloff L, Wilens SL, Bunim JJ. Arteritis of striated muscle in rheumatoid arthritis. Am J Pathol. 1951;27:157–73.
- Vollertsen RS, Conn DL, Ballard DJ, Ilstrup DM, Kaanar RE, Silverfield JC. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore). 1986;65:365–75.
- Puéchal X, Said G, Hilliquin P, Coste J, Job-Deslandre C, Lacroix C, Menkés CJ. Peripheral neuropathy with necrotizing vasculitis in rheumatoid vasculitis. Arthritis Rheum. 1995;38: 1618–29.
- Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum. 1996;39: 266–71.
- Luqmani RA, Watts RA, Scott DG, Bacon PA. Treatment of vasculitis in rheumatoid arthritis. Ann Med Interne (Paris). 1994; 145:566–76.
- Puéchal X, Menkés CJ. Prognosis in rheumatoid vasculitis (reply to letter, comments). Arthritis Rheum. 1996;39:1937–8.
- Voskuyl AE, van Duinen SG, Zwinderman AH, Breedveld FC, Hazes JM. The diagnostic value of perivascular infiltrates in muscle biopsies for the assessment of rheumatoid vasculitis. Ann Rheum Dis. 1998;57:114–7.
- Tribe CR, Scott DG, Bacon PA. Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol. 1981;34:843–50.
- Westedt ML, Herbrink P, Molenaar JL, de Vries E, Verlaan P, Stijnen T, Cats A, Lindeman J. Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int. 1985;5:209–14.
- Quismorio FP, Bearmore T, Kaufman RL, Mongan ES. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis. Clin Exp Immunol. 1983;52:333–40.
- Laskaria K, Ahmadi-Simab K, Lamken M, Csemok E, Gross WL, Hellmich B. Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis? Ann Rheum Dis. 2010;69:469-71.
- Bartels CM, Bridges AJ. Rheumatoid vasculitis: vanishing men-ace or target for new treatments? Curr Rheumatol Rep. 2010; 12(6):414–9.
- Guignard S, Gossec L, Bandinelli F, Dougados M. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis. Clin Exp Rheumatol. 2008;26(3 Suppl 49):523–9.
- Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vascu-litis. Am J Med. 1984;76:377–84.